Compound Detail
CHEMBL19224
PAPAVERINE 🧪 Phase III
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase III
Basic Information
| ChEMBL ID | CHEMBL19224 |
| Name | PAPAVERINE |
| Phase | Phase III |
| Structure Type | MOL |
| InChI Key | XQYZDYMELSJDRZ-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
30
Targets
69
Activities
3
Assay Types
8
PK Parameters
20
Publications
3
Known Names
7
Indications
Molecular Properties
339.4
MW (Da)
3.86
ALogP
5
HBA
0
HBD
49.8
PSA (Ų)
0.68
QED
0
Ro5 Violations
6
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
Indications
Digestive System Diseases Erectile Dysfunction Gastroenteritis Prostatic Neoplasms, Castration-Resistant Carcinoma, Non-Small-Cell Lung Lung Neoplasms Prostatic Hyperplasia
ATC Classification
A03AD01
papaverine
Level 1: ALIMENTARY TRACT AND METABOLISM
Level 2: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS
G04BE02
papaverine
Level 1: GENITO URINARY SYSTEM AND SEX HORMONES
Level 2: UROLOGICALS
G04BE52
papaverine, combinations
Level 1: GENITO URINARY SYSTEM AND SEX HORMONES
Level 2: UROLOGICALS
Activity Summary
IC50 65 meas. best 10.23
Ki 3 meas. best 7.77
Kd 1 meas. best 4.8
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Ileum CHEMBL613633 | IC50 | 10.23 | 8.086 | 0.1 | 5 |
| Unchecked CHEMBL612545 | Ki | 7.77 | 7.77 | 17.0 | 1 |
| cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A CHEMBL4409 | IC50 | 7.77 | 7.2681 | 17.0 | 16 |
| cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A CHEMBL6140 | IC50 | 7.44 | 7.44 | 36.0 | 4 |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A CHEMBL241 | IC50 | 6.55 | 6.255 | 284.0 | 4 |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A CHEMBL241 | Ki | 6.55 | 6.55 | 279.0 | 1 |
| Uterus CHEMBL4296544 | IC50 | 6.38 | 6.38 | 420.0 | 1 |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase 3B CHEMBL290 | Ki | 6.38 | 6.38 | 417.0 | 1 |
| Unchecked CHEMBL612545 | IC50 | 6.26 | 5.86 | 550.0 | 5 |
| Phosphodiesterase 3A CHEMBL3061 | IC50 | 6.21 | 6.21 | 620.0 | 1 |
| Cytochrome P450 2C19 CHEMBL3622 | IC50 | 6.12 | 6.12 | 762.0 | 1 |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase 3B CHEMBL290 | IC50 | 5.99 | 5.99 | 1030.0 | 1 |
| SARS-CoV-2 CHEMBL4303835 | IC50 | 5.96 | 5.96 | 1100.0 | 1 |
| 3',5'-cyclic-AMP phosphodiesterase 4D CHEMBL288 | IC50 | 5.85 | 5.85 | 1400.0 | 1 |
| Rattus norvegicus CHEMBL376 | IC50 | 5.81 | 5.81 | 1550.0 | 1 |
| 3',5'-cyclic-AMP phosphodiesterase 4A CHEMBL254 | IC50 | 5.8 | 5.8 | 1600.0 | 1 |
| Phosphodiesterase 4A CHEMBL3333 | IC50 | 5.77 | 5.77 | 1700.0 | 1 |
| Parainfluenza virus 5 CHEMBL5209661 | IC50 | 5.7 | 5.7 | 2000.0 | 1 |
| Influenza B virus CHEMBL613129 | IC50 | 5.7 | 5.7 | 2000.0 | 2 |
| Influenza A virus CHEMBL613740 | IC50 | 5.7 | 5.7 | 2000.0 | 4 |
| cGMP-dependent 3',5'-cyclic phosphodiesterase CHEMBL2652 | IC50 | 5.64 | 5.205 | 2300.0 | 2 |
| Serine hydroxymethyltransferase, mitochondrial CHEMBL4295747 | IC50 | 5.57 | 5.57 | 2691.5 | 1 |
| Ileum CHEMBL613680 | IC50 | 5.37 | 5.37 | 4230.0 | 1 |
| Phosphodiesterase; PDE3 & PDE4 CHEMBL2095153 | IC50 | 5.18 | 5.18 | 6600.0 | 1 |
| Voltage-gated inwardly rectifying potassium channel KCNH2 CHEMBL240 | IC50 | 5.14 | 5.14 | 7244.4 | 1 |
| Phosphodiesterase 1 CHEMBL2097166 | IC50 | 5.06 | 5.06 | 8800.0 | 1 |
| cGMP-specific 3',5'-cyclic phosphodiesterase CHEMBL1827 | IC50 | 5.06 | 5.06 | 8800.0 | 1 |
| Phosphodiesterase 1 CHEMBL2095150 | IC50 | 5.05 | 4.86 | 9000.0 | 2 |
| Phosphodiesterase 1 CHEMBL2111322 | IC50 | 4.92 | 4.8 | 12000.0 | 2 |
| Intestine CHEMBL613634 | Kd | 4.8 | 4.8 | 15848.9 | 1 |
| ATP-binding cassette sub-family C member 4 CHEMBL1743128 | IC50 | 4.64 | 4.64 | 23130.0 | 1 |
| Acetylcholinesterase CHEMBL4078 | IC50 | 4.61 | 4.61 | 24300.0 | 1 |
| Acetylcholinesterase CHEMBL220 | IC50 | 4.61 | 4.61 | 24330.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 11.0 | mL.min-1.kg-1 | Homo sapiens |
| CL | 11.0 | mL.min-1.kg-1 | Homo sapiens |
| CL | 11.0 | mL.min-1.kg-1 | Homo sapiens |
| CL | 11.0 | mL.min-1.kg-1 | Homo sapiens |
| Fu | 0.073 | - | Homo sapiens |
| Fu | 0.073 | - | Homo sapiens |
| MRT | 1.4 | hr | Homo sapiens |
| T1/2 | 1.8 | hr | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine